A number of studies have examined the effect of soluble plasma cytokine/chemokine responses on TB severity and response to treatment and several cytokines/chemokines such as TNFα, IFNγ, IL-1β, and IP-10 have been linked with disease outcome, presentation or severity (3–6). This evidence concerns the gene IL1B and tuberculosis.